0001213900-17-006380.txt : 20170612
0001213900-17-006380.hdr.sgml : 20170612
20170612172056
ACCESSION NUMBER: 0001213900-17-006380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170608
FILED AS OF DATE: 20170612
DATE AS OF CHANGE: 20170612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBIN ROBERT J.
CENTRAL INDEX KEY: 0001413631
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 17907356
MAIL ADDRESS:
STREET 1: 7901 SPRINGER ROAD
CITY: BETHESDA
STATE: MD
ZIP: 20817
FORMER NAME:
FORMER CONFORMED NAME: Rubin Robert Joseph
DATE OF NAME CHANGE: 20070926
4
1
f4060817rubin_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2017-06-08
0
0000812796
SOLIGENIX, INC.
SNGX
0001413631
RUBIN ROBERT J.
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
2.29
2017-06-08
4
A
0
13100
0
A
2027-06-07
Common Stock
13100
13100
D
The stock option vests ratably on each of September 8, 2017, December 8, 2017, March 8, 2018 and June 8, 2018.
/s/ Robert J. Rubin
2017-06-09